REFERENCES

• KesslerR.ChiuWT.DernierO.MerikangasKR.WaltersEE.Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.Arch Gen Psychiatry.20056261762715939839
   PubMed Web of Science ®Google Scholar
• TrivediM.RushAJ.WisniewskiSR.et aISTAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.Am J Psychiatry.2006163284016390886
   PubMed Web of Science ®Google Scholar
• DumanR.MonteggiaLM.A neurotrophic model for stress-related mood disorders.Biol Psychiatry.2006591116112716631126
   PubMed Web of Science ®Google Scholar
• KrishnanV.NestlerEJ.The molecular neurobiology of depression.Nature.200845589490218923511
   PubMed Web of Science ®Google Scholar
• SavitzJ.DrevetsWC .Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divideNeurosci Biobehav Rev.20093369977119428491
   PubMed Web of Science ®Google Scholar
• BermanR.CappielloA.AnandA.et alAntidepressant effects of ketamine in depressed patients.Biol Psychiatry.20004735135410686270
   PubMed Web of Science ®Google Scholar
• ZarateCA Jr.SinghJB.QuirozJA.et alA double-blind, placebo-controlled study of memantine in the treatment of major depression.Am J Psychiatry.200616315315516390905
   PubMed Web of Science ®Google Scholar
• FureyM.DrevetsWC.Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized placebo-controlled clinical trialArch Gen Psychiatry.2006631121112917015814
   PubMed Web of Science ®Google Scholar
• FureyM.KhannaA.HoffmanEM.DrevetsWC.Scopolamine produces larger antidepressant and antianxiety effects in women than in menNeuropsychopharmacology.2010352479248820736989
   PubMed Web of Science ®Google Scholar
• MaybergH.Targeted electrode-based modulation of neural circuits for depression.J Clin Invest.200911971772519339763
   PubMed Web of Science ®Google Scholar
• DrevetsW.PriceJL.FureyML.Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression.Brain Struct Fund.200821393118
   PubMed Web of Science ®Google Scholar
• MacQueenG.FrodlT.The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?Mol Psychiatry.20111625226420661246
   PubMed Web of Science ®Google Scholar
• BanasrM.ValentineGW.LiXY.GourleyS.TaylorJ.DumanRS.Chronic stress decreases cell proliferation in adult cerebral cortex of rat: Reversal by antidepressant treatment.Biol Psychiatry.20076249650417585885
   PubMed Web of Science ®Google Scholar
• RajkowskaG.Miguel-HidalgoJJ.WeiJ.et alMorphometric evidence for neuronal and glial prefrontal cell pathology in major depression.Biol Psychiatry.1999451085109810331101
   PubMed Web of Science ®Google Scholar
• RajkowskaG.Miguel-HidalgoJJ.Gliogenesis and glial pathology in depression.CMS Neurol Disord Drug Targets.20076219233
   PubMedGoogle Scholar
• KangH.VoletiB.HajszanT.et alDecreased expression of synapse-related genes and loss of synapses in major depressive disorder.Nat Med.2012181413141722885997
   PubMed Web of Science ®Google Scholar
• McEwenB.Physiology and neurobiology of stress and adaptation: central role of the brain.Physiol Rev.20078787390417615391
   PubMed Web of Science ®Google Scholar
• ShanskyR.MorrisonJH.Stress-induced dendritic remodeling in the medial prefrontal cortex: effects of circuit, hormones and rest.Brain Res.2009129310811319361488
   PubMed Web of Science ®Google Scholar
• LiuRJ.AghajanianGK.Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy.Proc Natl Acad Sci USA.200810535936418172209
   PubMed Web of Science ®Google Scholar
• McEwenB.The ever-changing brain: cellular and molecular mechanisms for the effects of stressful experiences.Dev Neurobiol.20127287889021898852
   PubMed Web of Science ®Google Scholar
• RoozendaalB.McEwenBS.ChattarjiS.Stress, memory and the amygdala.Nat Rev Neurosci.20091042343319469026
   PubMed Web of Science ®Google Scholar
• SahayA.HenR.Hippocampal neurogenesis and depression.Novartis Found Symp.200828915216018497101
   PubMedGoogle Scholar
• BoldriniM.UnderwoodMD.HenR.et alAntidepressants increase neural progenitor cells in the human hippocampus.Neuropsychopharmacology.2009342376238919606083
   PubMed Web of Science ®Google Scholar
• BanasrM.DwyerJM.DumanRS.Cell atrophy and loss in depression: reversal by antidepressant treatment.Curr Opin Cell Biol.20122373073721996102
   PubMed Web of Science ®Google Scholar
• RajkowskaG.O'DwyerG.TelekiZ.StockmeierCA.Miguel-HidalgoJJ.GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.Neuropsychopharmacology.20073247148217063153
   PubMed Web of Science ®Google Scholar
• DumanR.VoletiB.Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.Trends Neurosci.201235475622217452
   PubMed Web of Science ®Google Scholar
• SchmidtH.SheltonRC.DumanRS.Functional markers of depression: diagnosis, treatment and pathophysiology.Neuropsychopharmacology.2011362375239421814182
   PubMed Web of Science ®Google Scholar
• YuH.WangDD.WangY.LiuT.LeeFS.ChenZY.Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants.J Neurosci.2012324092410122442074
   PubMed Web of Science ®Google Scholar
• KrishnanV.HanMH.Mazei-RobisonM.et alAKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.Biol Psychiatry.20086469170018639865
   PubMed Web of Science ®Google Scholar
• TaliazD.StallN.DarDE.ZangenA.Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis.Mol Psychiatry.201015809219621014
   PubMed Web of Science ®Google Scholar
• ChenZ-Y.JingD.BathKG.et alGenetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior.Science.200631414014317023662
   PubMed Web of Science ®Google Scholar
• MagarihosA.LiCJ.GalToth J.et alEffect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons.Hippocampus.20112125326420095008
   PubMed Web of Science ®Google Scholar
• ChenH.PandeyGN.DwivediY.Hippocampal cell proliferation regulation by repeated stress and antidepressants.Neuroreport.20061786386716738477
   PubMed Web of Science ®Google Scholar
• LiuR.LeeFS.LiXY.BambicoF.DumanRS.AghajanianGK.Brain-derived neurotrophic factor val66met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.Biol Psychiatry.201271996100522036038
   PubMed Web of Science ®Google Scholar
• ChiaruttiniC.VicarioA.LiZ.et alDendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation.Proc Natl Acad Sci U S A.2009106164811648619805324
   PubMed Web of Science ®Google Scholar
• GattJ.NemeroffCB.Dobson-StoneC.et alInteractions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.Mol Psychiatry.20091468169519153574
   PubMed Web of Science ®Google Scholar
• ShelineY.GadoMH.KraemerHC.Untreated depression and hippocampal volume loss.Am J Psychiatry.20031601516151812900317
   PubMed Web of Science ®Google Scholar
• BessaJ.FerreiraD.MeloI.et alHippocampal neurogenesis induced by antidepressant drugs: an epiphenomenon in their mood-improving actions.Mol Psychiatry.20091476477318982002
   PubMed Web of Science ®Google Scholar
• MagarinosA.McEwenBS.Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors.Neurosci.1995698998
   PubMed Web of Science ®Google Scholar
• KarpovaN.PickenhagenA.LindholmJ.et alFear erasure in mice requires synergy between antidepressant drugs and extinction training.Science.20113341731173422194582
   PubMed Web of Science ®Google Scholar
• MayaVetencourt J.SaleA.ViegiA.et alThe antidepressant fluoxetine restores plasticity in the adult visual cortex.Science.200832038538818420937
   PubMed Web of Science ®Google Scholar
• HoltmaatA.SvobodaK.Experience-dependent structural synaptic plasticity in the mammalian brain.Nat Rev Neurosci.20091064765819693029
   PubMed Web of Science ®Google Scholar
• KesselsH.MalinowR.Synaptic AMPA receptor plasticity and behavior.Neuron.20096134035019217372
   PubMed Web of Science ®Google Scholar
• AanHet Rot M.ZarateCA Jr.CharneyDS.MathewSJ.Ketamine for depression: where do we go from here?Biol Psychiatry.20127253754722705040
   PubMed Web of Science ®Google Scholar
• DiazgranadosN.IbrahimL.BrutscheNE.et alA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.Arch Gen Psychiatry.20106779380220679587
   PubMed Web of Science ®Google Scholar
• LarkinG.BeautraisAL.A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.Int J Neuropsychopharmacol.2011141127113121557878
   PubMed Web of Science ®Google Scholar
• RobertsE.CurranHV.FristonKJ.MorganCJ.Abnormalities in white matter microstructure associated with chronic ketamine use.Neuropsychopharmacology.20143932933823929545
   PubMed Web of Science ®Google Scholar
• WangC.ZhengD.XuJ.LamW.YewDT.Brain damages in ketamine addicts as revealed by magnetic resonance imaging.Front Neuroanat.201372323882190
   PubMed Web of Science ®Google Scholar
• BehrensM.AliSS.DaoDN.et alKetamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase.Science.20073181645164718063801
   PubMed Web of Science ®Google Scholar
• BehrensM.SejnowskiTJ.Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?Neuropharmacology.20095719320019523965
   PubMed Web of Science ®Google Scholar
• LiN.LeeBY.LiuRJ.et almTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.Science.201032995996420724638
   PubMed Web of Science ®Google Scholar
• LiN.LiuR-J.DwyerJ.et alGlutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.Biol Psychiatry.20116975476121292242
   PubMed Web of Science ®Google Scholar
• CornwellB.SalvadoreG.FureyM.et alSynaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.Biol Psychiatry.2012725561
   Web of Science ®Google Scholar
• YoshiharaY.DeRoo M.MullerD.Dendritic spine formation and stabilization.Curr Opin Neurobiol.20091914615319523814
   PubMed Web of Science ®Google Scholar
• KoikeH.LijimaM.ChakiS.Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.Neuropharmacology.2011611419142321903115
   PubMed Web of Science ®Google Scholar
• AutryA.AdachiM.NosyrevaE.et alNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.Nature.2011475919521677641
   PubMed Web of Science ®Google Scholar
• LajeG.LallyN.MathewsD.et alBrain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.Biol Psychiatry.2012722728
   PubMed Web of Science ®Google Scholar
• ShirayamaY.IshidaH.IwataM.HazamaG-i.KawaharaR.DumanR.Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin blockade produces antidepressant effects.J Neurochem.2004901258126815312181
   PubMed Web of Science ®Google Scholar
• RussoS.NestlerEJ.The brain reward circuitry in mood disorders.Nat Rec Neurosci.201314609625
   PubMed Web of Science ®Google Scholar
• SchmidtH.DumanRS.Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.Neuropsychopharmacology.2010352378239120686454
   PubMed Web of Science ®Google Scholar
• BlierP.Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.Biol Psychiatry.20137423823923885752
   PubMed Web of Science ®Google Scholar
• KapurS.SeemanP.NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia.Mol Psychiatry.2002783784412232776
   PubMed Web of Science ®Google Scholar
• CoatesK.FloodP.Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.Br J Pharmacol.200113487187911606328
   PubMed Web of Science ®Google Scholar
• SanacoraG.ZarateCA.KrystalJH.ManjiHK.Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.Nat Rev Drug Discov.2008742643718425072
   PubMed Web of Science ®Google Scholar
• Lima-OjedaJ.VogtMA.PfeifferN.et alPharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain.Prog Neuropsychopharmacol Biol Psychiatry.201345283323643674
   PubMed Web of Science ®Google Scholar
• PreskornS.BakerB.OmoK.KolluriS.MennitiFS.LandenJW.A placebo-controlled trial of the NR2B subunit specific NMDA antagonist CP101,606 plus paroxetine for treatment resistant depression (TRD). Paper presented at the American Psychological Association meeting; 2007.
   Google Scholar
• ZarateCA Jr.DuJ.QuirozJ.et alRegulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutmatergic system.Ann N Y Acad Sci.2003100327329114684452
   PubMed Web of Science ®Google Scholar
• ReisbergB.DoodyR.StofflerA.SchmittF.FerrisS.MobiusHJ.Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease.N Engl J Med.20033481333134112672860
   PubMed Web of Science ®Google Scholar
• ZarateCJ.MathewsD.IbrahimL.et alA randomized trial of a lowtrapping nonselective N-methyl-d-aspartate channel blocker in major depression.Biol Psychiatry.20137425726423206319
   PubMed Web of Science ®Google Scholar
• SanacoraG.SmithMA.PathakS.et alLanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects.Mol Psychiatry. 2013. Epub ahead of print.
   Google Scholar
• BurgdorfJ.ZhangXL.NicholsonKL.et alGLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.Neuropsychopharmacology.20123872974223303054
   PubMed Web of Science ®Google Scholar
• MoghaddamB.AdamsB.VermaA.DalyD.Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.J Neurosci.19971729122917
   Web of Science ®Google Scholar
• HomayounH.MoghaddamB.NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.J Neurosci.200727114961150017959792
   PubMed Web of Science ®Google Scholar
• ShigemotoR.KinoshitaA.WadaE.et alDifferential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus.J Neurosci.199717750375229295396
   PubMed Web of Science ®Google Scholar
• HascupE.HascupKN.StephensM.et alRapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex.J Neurochem.20101151608162020969570
   PubMed Web of Science ®Google Scholar
• BespalovA.van GaalenMM.SukhotinaIA.et alBehavioral characterization of the mGlu group ll/lll receptor antagonist, LY-341495, in animal models of anxiety and depression.Eur J Pharmacol.20085929610218634781
   PubMed Web of Science ®Google Scholar
• ChakiS.YoshikawaR.HirotaS.et alMGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.Neuropharmacology.20044645746714975669
   PubMed Web of Science ®Google Scholar
• MarekG.Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition.Eur J Pharmacol.2010639819020371229
   PubMed Web of Science ®Google Scholar
• DwyerJM.LepackAE.DumanRS.mTOR activation is required for the antidepressant effects of mGluR2/3 blockade.Int J Neuropsychopharmacol.20121542943422114864
   PubMed Web of Science ®Google Scholar
• DwyerJ.LepackAE.DumanRS.mGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure.J Mol Psych. In press.
   Google Scholar
• MaengS.ZarateCA Jr.DuJ.et alCellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5methylisoxazole-4-propionic acid receptors.Biol Psychiatry.20086334935217643398
   PubMed Web of Science ®Google Scholar
• AraiA.KesslerM.RogersG.LynchG.Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.Mol Pharmacol.20005880281310999951
   PubMed Web of Science ®Google Scholar
• LauterbornJ.LynchG.VanderklishP.AraiA.GallCM.Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.J Neurosci.20002082110627576
   PubMed Web of Science ®Google Scholar
• AraiA.KesslerM.Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior.Curr Drug Targets.2007858360217504103
   PubMed Web of Science ®Google Scholar
• LynchA.WalshC.DelaneyA.NolanY.CampbellVA.LynchMA.Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10— a role for IL-1b?J Neurochem.20048863564614720213
   PubMed Web of Science ®Google Scholar
• JourdiH.HsuYT.ZhouM.QinQ.BiX.BaudryM.Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation.J Neurosci.2009298688869719587275
   PubMed Web of Science ®Google Scholar
• BaiF.LiX.ClayM.LindsromT.SkolnickP.Intra- and interstrain differences in models of “behavior despair”.Pharmacol Biochem Behav.20017018719211701187
   PubMed Web of Science ®Google Scholar
• BaiF.BergeronM.NelsonDL.Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus.Neuropharmacology.2003441013102112763094
   PubMed Web of Science ®Google Scholar
• VoletiB.NavarriaA.LiuRJ.et alScopolamine rapidly increases mTORC1 signaling, synaptogenesis, and antidepressant behavioral responses.Biol Psychiatry.20137474274923751205
   PubMed Web of Science ®Google Scholar
• BeurelE.SongL.JopeRS.Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.Mol Psychiatry.2011161068107021502951
   PubMed Web of Science ®Google Scholar
• LiuRJ.FuchikamiM.DwyerJM.LepackAE.DumanRS.AghajanianGK.GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.Neuropsychopharmacology.2013382268227723680942
   PubMed Web of Science ®Google Scholar
• DrevetsW.FureyML.Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.Biol Psychiatry.20106743243820074703
   PubMed Web of Science ®Google Scholar
• VecseyC.PeixotoL.ChoiJH.et alGenomic analysis of sleep deprivation reveals translational regulation in the hippocampus.Physiol Genomics.20124498199122930738
   PubMed Web of Science ®Google Scholar
• CaruanaD.WarburtonEC.BashirZl.Induction of activity-dependent LTD requires muscarinic receptor activation in medial prefrontal cortex.J Neurosci.201131184641847822171048
   PubMed Web of Science ®Google Scholar
• HarsingL.ZigmondMJ.Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.Brain Res Bull.1998456076139566505
   PubMed Web of Science ®Google Scholar
• HughesZ.LiuF.MarquisK.et alEstrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders.Curr Mol Pharmacol.2009221523620021460
   PubMedGoogle Scholar
• WoolleyC.McEwenBS.Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism.J Neurosci.199414768076877996203
   PubMed Web of Science ®Google Scholar
• DowlatiY.HerrmannN.SwardfagerW.et alA meta-analysis of cytokines in major depression.Biol Psychiatry .20106744645720015486
   PubMed Web of Science ®Google Scholar
• HowrenM.LamkinDM.SulsJ.Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.Psychosom Med.20097117118619188531
   PubMed Web of Science ®Google Scholar
• SchiepersO.WichersMC.MaesM.Cytokines and major depression.Prog Neuropsychopharmacol Biol Psychiatry.20052920121715694227
   PubMed Web of Science ®Google Scholar
• lwataM.OtaKT.DumanRS.The inflammasome: pathways linking psychological stress, depression, and systemic illnesses.Brain Behav irnmun.201331105114
   PubMed Web of Science ®Google Scholar
• KrishnanV.HanM-H.GrahamDL.et alMolecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.Cell.200713139140417956738
   PubMed Web of Science ®Google Scholar
• RaisonC.RutherfordRE.WoolwineBJ.et alA randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.JAMA Psychiatry.201370314122945416
   PubMed Web of Science ®Google Scholar
• KooJ.DumanRS.IL-1B is an essential mediator of the anti-neurogenic and anhedonic effects of stress.Proc Natl Acad Sci USA.200810575175618178625
   PubMed Web of Science ®Google Scholar
• PaolicelliR.BolascoG.PaganiF.et alSynaptic pruning by microglia is necessary for normal brain development.Science.20113331456145821778362
   PubMed Web of Science ®Google Scholar